More on ANTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $5.00 |
|
|||
| Open | $5.00 | ||||
| 52 Wk High | $48.59 | ||||
| 52 Wk Low | $40.72 | ||||
| Day High | $5.44 | ||||
| Day Low | $5.00 | ||||
| P/E | N/A | ||||
| EPS | $-0.01 | ||||
| Volume | 168,321 | ||||
- Form 8-K AN2 Therapeutics, Inc. For: Jun 03
- Form 8-K AN2 Therapeutics, Inc. For: Jun 04
- AN2 Therapeutics reports positive data for Chagas disease drug
- AN2 Therapeutics Reports Positive Enabling Data Supporting Advancement of Oral AN2-502998 to Phase 2 Study for Chronic Chagas Disease
- Form 4 AN2 Therapeutics, Inc. For: May 29 Filed by: Williams Sarah Joanne
- AN2 Therapeutics to Present at 2026 Jefferies Global Healthcare Conference
- Form SCHEDULE 13G/A AN2 Therapeutics, Inc. Filed by: Almitas Capital LLC
- Leerink Partners Upgrades AN2 Therapeutics (ANTX) to Outperform
- AN2 Therapeutics, Inc. (ANTX) Misses Q1 EPS by 6c
- Form 10-Q AN2 Therapeutics, Inc. For: Mar 31
Entities mentioned with ANTX
- FDA | View Related Stories »
- 13G | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- Cowen & Co | View Related Stories »
- Show More...
